VivoSim Labs, Inc. (VIVS) Income Statement
VIVS FY2026 at a glance
Fiscal year ended March 31, 2026 · U.S. dollarsVIVS revenue and net income
Where VIVS's revenue goes
FY2026Each bar shows an amount and its share of revenue. VIVS kept −10,567.2% of revenue as net income.
VIVS profit margins
VIVS growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −9.0% | −29.3% | — | −21.5% |
| Gross profit | −5.8% | −29.3% | — | −21.5% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
VIVS quarterly EPS vs estimates
VivoSim Labs beat the analyst EPS estimate in 5 of the last 5 quarters. Next report: November 5, 2026.
VIVS income statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $131,000 | $144,000 | $109,000 | $370,000 | $1.5M | $0 | $2.2M | $3.1M | $4.6M | $4.2M |
| Cost of revenue | $0 | $5,000 | $0 | $0 | $0 | $0 | $328,000 | $482,000 | $1.0M | $956,000 |
| Gross profit | $131,000 | $139,000 | $109,000 | $370,000 | $1.5M | $0 | $1.9M | $2.6M | $3.6M | $3.3M |
| Research & development | $4.2M | $5.0M | $5.5M | $8.9M | $3.3M | $1.1M | $5.3M | $14.8M | $18.0M | $19.5M |
| Sales, general & admin | $7.2M | $7.7M | $9.6M | $9.1M | $9.6M | $15.7M | $17.1M | $14.7M | — | — |
| Total operating expenses | $11.4M | $12.8M | $15.2M | $18.1M | $13.0M | $16.8M | $23.3M | $29.9M | $38.8M | $41.8M |
| Operating income | −$11.2M | −$12.6M | −$15.1M | −$17.7M | −$11.5M | −$16.8M | −$21.5M | −$27.3M | −$35.3M | −$38.6M |
| Interest income | $267,000 | $140,000 | $405,000 | $454,000 | $8,000 | $15,000 | — | — | — | — |
| Interest expense | $12,000 | $10,000 | $0 | — | — | — | — | — | — | — |
| Income before taxes | −$13.6M | −$2.5M | −$14.7M | −$17.3M | −$11.4M | −$16.8M | −$18.7M | −$26.6M | −$34.8M | −$38.4M |
| Income taxes | −$2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $3,000 | $2,000 | $23,000 |
| Net income | −$13.8M | −$2.5M | −$14.7M | −$17.3M | −$11.4M | −$16.8M | −$18.7M | −$26.6M | −$34.8M | −$38.4M |
| EBITDA | −$13.4M | −$2.2M | −$14.4M | −$17.0M | −$11.3M | −$14.0M | −$20.3M | −$26.3M | −$34.0M | −$37.4M |
| EPS (diluted) | −$5.36 | −$2.51 | −$23.88 | −$11.39 | −$1.25 | −$3.11 | −$30.64 | −$317.79 | −$61.03 | −$67.30 |
| Gross margin | 100.0% | 96.5% | 100.0% | 100.0% | 100.0% | — | 85.1% | 84.4% | 77.6% | 77.4% |
| Operating margin | −8,567.9% | −8,761.1% | −13,840.4% | −4,792.2% | −765.3% | — | −977.9% | −882.4% | −766.3% | −911.9% |
| Net margin | −10,567.2% | −1,727.8% | −13,459.6% | −4,664.6% | −763.2% | — | −852.0% | −861.7% | −756.1% | −908.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18,000 | $40,000 | $26,000 | $28,000 | $37,000 | $51,000 | $24,000 | $30,000 | $39,000 | $29,000 | $5,000 | $0 |
| Cost of revenue | $263,000 | $0 | $0 | $0 | $0 | $0 | $2,000 | $1,000 | $2,000 | $0 | $0 | — |
| Gross profit | $18,000 | $40,000 | $26,000 | $28,000 | $37,000 | $51,000 | $22,000 | $29,000 | $37,000 | $29,000 | $5,000 | — |
| Research & development | $1.1M | $1.1M | $1.1M | $923,000 | $1.0M | $859,000 | $1.8M | $984,000 | $1.4M | $1.1M | $1.4M | $1.3M |
| Sales, general & admin | $1.6M | $2.1M | $1.6M | $1.7M | $1.9M | $2.3M | $1.7M | $1.6M | $2.0M | $2.0M | $2.2M | $2.8M |
| Total operating expenses | $2.8M | $3.2M | $2.8M | $2.7M | $3.0M | $3.2M | $3.5M | $2.6M | $3.4M | $3.1M | $3.7M | $4.1M |
| Operating income | −$2.8M | −$3.2M | −$2.8M | −$2.6M | −$2.9M | −$3.2M | −$3.5M | −$2.6M | −$3.4M | −$3.1M | −$3.7M | −$4.1M |
| Interest income | $28,000 | $36,000 | $63,000 | $92,000 | $76,000 | $11,000 | $26,000 | $59,000 | $44,000 | $51,000 | $76,000 | — |
| Interest expense | $4,000 | $4,000 | $4,000 | $0 | $4,000 | $5,000 | $5,000 | $0 | $0 | — | $0 | — |
| Income before taxes | −$1.3M | −$5.8M | −$2.7M | −$2.5M | −$2.8M | $6.9M | −$3.4M | −$2.5M | −$3.3M | −$3.0M | −$3.6M | −$4.0M |
| Income taxes | $3,000 | — | — | $2,000 | — | — | — | — | $2,000 | — | — | — |
| Net income | −$1.3M | −$5.8M | −$2.7M | −$2.5M | −$2.8M | $6.9M | −$3.4M | −$2.5M | −$3.3M | −$3.0M | −$3.6M | −$4.0M |
| EBITDA | −$1.3M | −$5.7M | −$2.6M | −$2.5M | −$2.8M | $6.9M | −$3.4M | −$2.5M | −$3.3M | −$3.0M | −$3.5M | −$3.9M |
| EPS (diluted) | −$0.25 | −$2.21 | −$1.03 | −$0.98 | −$1.14 | $4.21 | −$2.28 | −$1.68 | −$2.76 | −$8.04 | −$4.80 | −$5.52 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 91.7% | 96.7% | 94.9% | 100.0% | 100.0% | — |
| Operating margin | −15,327.8% | −7,967.5% | −10,576.9% | −9,410.7% | −7,878.4% | −6,184.3% | −14,450.0% | −8,693.3% | −8,682.1% | −10,675.9% | −73,600.0% | — |
| Net margin | −7,433.3% | −14,410.0% | −10,350.0% | −9,089.3% | −7,683.8% | 13,435.3% | −14,362.5% | −8,496.7% | −8,574.4% | −10,500.0% | −72,080.0% | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in VIVS's financial statements (latest annual report filed July 14, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
VIVS financial results
In fiscal year 2026 (ended March 31, 2026), VivoSim Labs reported revenue of $0.1 million, down 9.0% from the year before. It had a net loss of $13.8 million, a net profit margin of −10,567.2%. Diluted earnings per share came to −$5.36.
See the VIVS stock overview for the latest quote and news, or the VIVS chart for price history and technical indicators.
VIVS income statement FAQ
What is VivoSim Labs's annual revenue?
VivoSim Labs reported total revenue of $0.1 million for fiscal year 2026, which ended on March 31, 2026. That was down 9.0% from $0.1 million the previous year.
Is VivoSim Labs profitable?
No. VivoSim Labs reported a net loss of $13.8 million in fiscal 2026, a net profit margin of −10,567.2%; its operating margin was −8,567.9%.
What is VivoSim Labs's gross margin?
VivoSim Labs's gross margin was 100.0% in fiscal 2026: for every $100 of revenue, VivoSim Labs kept $100 after the direct cost of its products and services.
How much does VivoSim Labs spend on research and development?
VivoSim Labs spent $4.2 million on research and development in fiscal 2026, 3,197.7% of revenue.
What are VivoSim Labs's earnings per share?
VivoSim Labs earned $-5.36 per diluted share in fiscal 2026, compared with $-2.51 a year earlier.
When will VivoSim Labs report its next earnings?
VivoSim Labs is expected to report results for the quarter ending September 30, 2026 on November 5, 2026.
When does VivoSim Labs's fiscal year end?
VivoSim Labs's fiscal year ends in March. The latest annual report covers the year ended March 31, 2026 and was filed on July 14, 2026.